enGene Holdings • ENGN
enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients.
Ratings
0 / 5
0 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Jason D. Hanson$680.5M
Market Cap • 06/05/20242023
(há 1 ano)
2023
(1 year ago)
NASDAQ
Listagem
Saint-Laurent
Sede • QCValuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
ENGNSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.